Literature DB >> 15501998

A case of reversible posterior leucoencephalopathy syndrome after rituximab infusion.

C P Mavragani, P G Vlachoyiannopoulos, N Kosmas, I Boletis, A G Tzioufas, M Voulgarelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15501998     DOI： 10.1093/rheumatology/keh305

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  12 in total

1.  [Acute bilateral loss of vision in posterior reversible encephalopathy syndrome].

Authors:  K S Bonsel; I Oberacher-Velten; K Hufendiek; H Jägle
Journal:  Ophthalmologe       Date:  2013-03       Impact factor: 1.059

Review 2.  Neurologic Complications of Commonly Used Drugs in the Hospital Setting.

Authors:  Elliot T Dawson; Sara E Hocker
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

3.  Posterior reversible encephalopathy syndrome (PRES) attributed to mycophenolate mofetil during the management of SLE: a case report and review.

Authors:  Lei Zhang; Jian Xu
Journal:  Am J Clin Exp Immunol       Date:  2018-02-05

Review 4.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

5.  Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature.

Authors:  Pingping Zhang; Xiaofeng Li; Yating Li; Jing Wang; Huasong Zeng; Xiaofeng Zeng
Journal:  Biomed Rep       Date:  2014-11-07

6.  Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors:  Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 7.  Seizures and epilepsy in cancer: etiologies, evaluation, and management.

Authors:  Jai Grewal; Harpreet K Grewal; Arthur D Forman
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

8.  Rituximab as a possible cause of posterior reversible encephalopathy syndrome.

Authors:  Ahmed Imran Siddiqi
Journal:  Australas Med J       Date:  2011-09-30

Review 9.  Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review.

Authors:  Mayu Uematsu-Uchida; Takehiro Ohira; Shigeki Tomita; Hiroshi Satonaka; Akihiro Tojo; Toshihiko Ishimitsu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

10.  Posterior Reversible Encephalopathy Syndrome in a Patient With Microscopic Polyangiitis: A Case Report and Literature Review.

Authors:  Jing Xu; Ying Ding; Zhen Qu; Feng Yu
Journal:  Front Med (Lausanne)       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.